资源中心

BsAb: Engineered antibody binding two antigens, activating immune cells, inhibiting tumor signaling. Market: $5.8B in 2023, expecting multi-billion growth by 2030.

Cullinan made an initial payment of $25 million and committed up to $600 million in milestone payments, along with a potential royalty of nearly 20% on sales.

Innopedia is a robust database designed to provide researchers with enhanced research tools and data support. The database offers browsing, searching, and analytical capabilities for tumor cell lines, engineered cell lines, and standard antibodies.

Kinases regulate nearly all aspects of cellular activities, and alterations in their expression or gene mutations can lead to the development of cancer and other diseases.

Antibodies, CAR-T cells, and other biopharmaceuticals rely on the specificity of their target binding, which is a critical factor in assessing the quality of these drugs.

This is the description of the resource

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic

K-ras was the first identified oncogene in the cellular genome, KRAS protein can bind GDP/GTP and possess intrinsic